Interleukin-1 and Its Receptor Antagonist in Rats and Mice
Author Information
Author(s): P. BjrkcA, K. Ohlsson
Primary Institution: Department of Surgical Pathophysiology, University of Lund, Maim6 General Hospital, Sweden
Hypothesis
The study investigates the ability of interleukin-1 to induce an acute phase protein response and the influence of its receptor antagonist.
Conclusion
Interleukin-1 induces an acute phase protein response and degranulation of polymorphonuclear leukocytes, which can be influenced by the interleukin-1 receptor antagonist.
Supporting Evidence
- Interleukin-1 increased plasma levels of acute phase proteins in rats and mice.
- The interleukin-1 receptor antagonist blocked the increase of certain proteins in a dose-dependent manner.
- Polymorphonuclear leukocyte degranulation was measured by increased cathepsin G plasma levels after interleukin-1 injection.
Takeaway
When the body gets hurt, it releases special proteins to help heal. This study looked at how a protein called interleukin-1 helps with that and how a blocker can change its effects.
Methodology
The study used ELISA to measure plasma levels of proteins in rats and mice after administering interleukin-1 and its receptor antagonist.
Participant Demographics
Male Wistar rats and Balb/c mice were used in the experiments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website